CWM
EMN icon

Calamos Wealth Management’s Eastman Chemical EMN Stock Holding History

Calamos Wealth Management’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,117
Closed -$314K – 499
2026
Q1 		$314K Buy
+4,117
New +$297K 0.01% 374
2015
Q1 		– Sell
-8,668
Closed -$658K – 239
2014
Q4 		$658K Sell
8,668
-636
-7% -$50.3K 0.19% 158
2014
Q3 		$753K Buy
9,304
+40
+0.4% +$3.34K 0.22% 150
2014
Q2 		$809K Sell
9,264
-190
-2% -$16.5K 0.23% 141
2014
Q1 		$815K Buy
9,454
+878
+10% +$72K 0.24% 139
2013
Q4 		$692K Sell
8,576
-144
-2% -$11.2K 0.21% 151
2013
Q3 		$679K Buy
8,720
+253
+3% +$19.5K 0.22% 140
2013
Q2 		$593K Buy
+8,467
New +$590K 0.21% 133

Other funds holding EMN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Calamos Wealth Management's EMN Position: Q2 2026 in Review

Calamos Wealth Management sold out of Eastman Chemical (EMN) in Q2 2026, closing a stake of 4,117 shares — an estimated $314K sold.

Calamos Wealth Management first reported a position in EMN in Q2 2013 and held it in 8 quarters. The position peaked at $815K in Q1 2014. 644 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Calamos Wealth Management reported no remaining Eastman Chemical position as of Q2 2026 after selling out during the quarter.
  • Calamos Wealth Management sold 4,117 Eastman Chemical shares in Q2 2026, an estimated $314K.
  • Calamos Wealth Management first reported a position in Eastman Chemical in Q2 2013 and held it in 8 quarters.
  • Calamos Wealth Management's Eastman Chemical position peaked at $815K in Q1 2014.
  • 644 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Calamos Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.